Unique ID issued by UMIN | UMIN000047904 |
---|---|
Receipt number | R000054613 |
Scientific Title | Clinical research to evaluate beta-amyloid deposition in the brain of patients with Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) |
Date of disclosure of the study information | 2022/05/31 |
Last modified on | 2022/05/31 17:45:09 |
Clinical research to evaluate beta-amyloid deposition in the brain of patients with Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB)
Amyloid PET studies in PDD and DLB
Clinical research to evaluate beta-amyloid deposition in the brain of patients with Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB)
Amyloid PET studies in PDD and DLB
Japan |
Parkinson's disease with dementia (PDD)
Dementia with Lewy bodies (DLB)
Neurology |
Others
NO
To evaluate beta-amyloid deposition in the brain of patients with Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB)
Others
To determine whether information and samples obtained from routine clinical practice are predictive of amyloid deposition
beta-amyloid deposition in the brain
Observational
40 | years-old | <= |
80 | years-old | >= |
Male and Female
Patients with PDD or DLB who are attending or being admitted to the Department of Neurology, Juntendo University Hospital, Juntendo University School of Medicine, will be included in the study.
PDD is diagnosed as Clinically Established PD or Clinically Probable PD by MDS Clinical Diagnostic Criteria for Parkinson's Disease, and PDD is defined as the onset of Dementia 2 years later.
DLB is defined as patients diagnosed with Probable DLB (almost certain) by the Clinical Diagnostic Criteria for Dementia with Lewy Bodies (2017)
Amyloid PET and neuropsychological testing can be performed
For whom 123I-Ioflupane SPECT testing has been performed
IMP-SPECT test performed has been performed
Age less than 40 years and greater than 81 years at the time consent was obtained
Patients with more than moderate multiple cerebral infarctions
Those with a history of epileptic seizures within 2 years
Other subjects deemed inappropriate as research subjects by the principal investigator
60
1st name | Noriko |
Middle name | |
Last name | Nishikawa |
Juntendo University School of Medicine
Department of Neurology
113-8421
2-1-1 Hongo Bunkyo Tokyo
03-3813-3111
n.nishikawa.ts@juntendo.ac.jp
1st name | Noriko |
Middle name | |
Last name | Nishikawa |
Juntendo University School of Medicine
Department of Neurology
113-8421
2-1-1 Hongo Bunkyo Tokyo
03-3813-3111
n.nishikawa.ts@juntendo.ac.jp
Juntendo University School of Medicine
Eisai Co., Ltd.
Profit organization
Nihon Medi-Physics Co.,Ltd.
Juntendo University Hospital Clinical Research and Trial Center
3-1-3,Hongo,Bunkyo-ku,Tokyo
03-3814-5672
hongo-rinri@juntendo.ac.jp
YES
E22-0046
Juntendo University Hospital Clinical Research and Trial Center
2022 | Year | 05 | Month | 31 | Day |
Unpublished
Open public recruiting
2022 | Year | 04 | Month | 16 | Day |
2022 | Year | 05 | Month | 20 | Day |
2022 | Year | 05 | Month | 25 | Day |
2024 | Year | 03 | Month | 31 | Day |
Amyloid PET will be performed in patients with PDD and DLB who have undergone or will undergo a detailed clinical evaluation to determine how beta-amyloid deposition in the brain affects the disease status
2022 | Year | 05 | Month | 31 | Day |
2022 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054613